Veradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?

Veradigm logo with Business Services background

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $5.46, but opened at $4.55. Veradigm shares last traded at $4.80, with a volume of 2,089 shares trading hands.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on MDRX. Stephens boosted their price objective on Veradigm from $7.00 to $13.00 and gave the company an "equal weight" rating in a research report on Friday, January 31st. StockNews.com assumed coverage on Veradigm in a report on Wednesday. They issued a "hold" rating for the company.

Get Our Latest Stock Analysis on MDRX

Veradigm Trading Up 5.0 %

The stock's 50 day moving average is $9.22 and its 200 day moving average is $9.52.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

See Also

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

7 Inflation-Proof Stocks to Protect Your Portfolio
Palantir’s Explosive Growth: Buy Now or Wait for a Dip?
5 Stocks to BUY NOW in February 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines